All highlights of the virtual conference coverage of the 63rd ASH Annual Meeting are now available online
17.02.2022 13:43
A few weeks ago, the annual meeting of the American Society of Hematology (ASH) took place in hybrid form, both on site in Atlanta, Georgia, and digitally. The ASH Annual Meeting brings together hematologists and hemato-oncologists from around the world to discuss the latest research in hematology and hemato-oncology. A German team of experts prepared the most notable studies as part of the ASH today conference reporting. All of the articles are now available to all interested doctors free of charge and on demand at www.medtoday.de.
All contributions free of charge, on demand and with download of the presentation slides
A German-speaking team of 41 hematologists and hemato-oncologists will present and discuss study results from 14 entities at ASH today. In addition to the study highlights and expert discussions, introductory state-of-the-art contributions are also offered that prepare for the various topic areas and the research results to be expected at the ASH Annual Meeting. The congress reporting is rounded off by the satellite symposiums and the large final discussion on the Practice Changing Studies. Here the experts discuss which results of the ASH Annual Meeting will change and shape everyday treatment of tomorrow. All contributions are available to you www.medtoday.de now available free on demand for a year. All presentation slides can be downloaded in PDF format. You can gain access to the platform by registering free of charge www.medtoday.de.
ASH today: Support and Licensing
ASH today takes place in a media partnership with the Deutsches Ärzteblatt (DÄ) and is sponsored by the American Society of Hematology (ASH®) licensed.
ASH today: A multi-sponsorship project
ASH today is an initiative of art tempi communications gmbh and was made possible through multi-sponsorship from the following companies: Platin: Bristol Myers Squibb GmbH & Co. KG; Silver: Sanofi-Aventis Deutschland GmbH; Bronze: Novartis Pharma GmbH, Amgen GmbH, Gilead Sciences GmbH, Pfizer Deutschland GmbH; Associated: Janssen-Cilag GmbH, GlaxoSmithKline GmbH.